Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06354790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History Study of Children With LAMA2-related Dystrophies

Study acronym: LAMA2
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jun 14, 2027 to Dec 4, 2027
    • Start date changed from estimate of Nov 1, 2024 to Dec 5, 2024
    • Site details revised at 4 of 4 sites
    v3
  2. Start date: Jun 15, 2024 to Nov 1, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this natural history study is to characterize the disease course, characteristics in paediatric population of LAMA2-RD (related dystrophies) patients. The aim of the study is to establish a well-described cohort of patients in France with LAMA2-RD for prospective follow-up and recruitment for future clinical trials. Participants will be follow up during a two years period regarding exhaustive aspects of the pathology: * Muscular function * Respiratory function * Cognitive phenotyping * Quality of life * Growth parameters * Biomarkers
Trial Details
NCT Number NCT06354790
Lead Sponsor Institut de Myologie, France
Collaborators: Association Française contre les Myopathies (AFM), Paris
Conditions
(from sponsor)		 Merosin Deficient Congenital Muscular Dystrophy
Related terms Muscular dystrophy congenital, merosin negative
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov